Creative Bioarray

Creative Bioarray： Biobank - Human& Animal Tissue Bank, Research Use Cells - Primary cells, Tumor cells, Stem cells, CABR™ Probes

[Creative Bioarray @CreaBioarray]

Creative Bioarray offers well-characterized pulmonary fibrosis animal models to support preclinical drug efficacy evaluation, mechanistic research, and translational decision making.
https://t.co/OZBoe2d3Dm
https://t.co/2dltiHIUDO

[Creative Bioarray @CreaBioarray]

Creative Bioarray provides liver fibrosis animal models for preclinical drug discovery, efficacy evaluation, and translational liver disease research. Our platform includes chemical-induced, and surgery-induced models for anti-fibrotic drug development. https://t.co/FHB52K8KlH

[Creative Bioarray @CreaBioarray]

Creative Bioarray offers a well-established and widely validated High-Fat Diet-Induced Obesity (DIO) model for translational research and innovative therapeutic drug development. https://t.co/IY2t1w7pQS

[Creative Bioarray @CreaBioarray]

OncoSelect™ Tumor Efficacy Screening Panel integrates well-characterized tumor cell lines, drug-resistant derivatives, and tumor microenvironment components to bridge the gap between in vitro pharmacology and clinical translation. https://t.co/YzFMig4LK5

[Creative Bioarray @CreaBioarray]

Primary cells covering 60+ cell types from 80+ tissue sources across 20+ species, low-passage and high-purity for human and animal biomedical research. https://t.co/V3QZ7dyMKq

[Creative Bioarray @CreaBioarray]

Curated portfolio of 2,000+ tumor cell lines spanning 100+ tissues and 200+ cancer diseases, STR-authenticated and mycoplasma-tested for oncology research. https://t.co/tJg8igapEx

[Creative Bioarray @CreaBioarray]

Access over 100,000+ ethically sourced, clinically annotated biospecimens — tissue blocks, tissue sections, FFPE pellets, TMAs, and biofluids. https://t.co/VH2U9ACay7

[Creative Bioarray @CreaBioarray]

Creative Bioarray maintains a large, ethnically diverse donor pool of HLA-typed primary cells.
https://t.co/CAdy4dwCUi

[Creative Bioarray @CreaBioarray]

Short (<6 h) and long (>8 h) sleep duration, compared with a normal sleep duration (6–8 h), are associated with increased risk of systemic diseases with evidence from genetic correlations and time-to-incident survival predictions. https://t.co/M6vVkkvjMK

[Creative Bioarray @CreaBioarray]

Access our extensive collection of ferroptosis-sensitive cell lines and validated animal models, enabling rapid translation from discovery to preclinical validation. https://t.co/z0SOReequB

[Creative Bioarray @CreaBioarray]

Accelerate Your Discovery with Characterized HLA-Typed Cell Products. https://t.co/CAdy4dwCUi

[Creative Bioarray @CreaBioarray]

With years of expertise, Creative Bioarray serves as a trusted partner in safety evaluation, specializing in preclinical toxicology testing. Our comprehensive testing platform supports applications throughout all stages of product development. https://t.co/qjSNYwveIc

[Creative Bioarray @CreaBioarray]

Power your precision oncology research with our systematic library of 2,000+ Tumor Cells. https://t.co/tJg8igapEx

[Creative Bioarray @CreaBioarray]

Creative Bioarray provides direct access to over 2,500 individual lots of high-quality human and animal primary cells. https://t.co/V3QZ7dyeUS

[Creative Bioarray @CreaBioarray]

Immunoglobulin E (IgE)-sensitized mast cells (IgE-MCs) for targeted drug delivery and augmented cancer immunotherapy
https://t.co/iggwZButD0
https://t.co/V3QZ7dyMKq

[Creative Bioarray @CreaBioarray]

A 100% Healing Rate: Stem Cell Exosomes Make Diabetic Foot Ulcers Vanish, With Zero Recurrence in 24 Months.
https://t.co/CGxxQzteEX
https://t.co/32TIVBN1TI

[Creative Bioarray @CreaBioarray]

pTα enhances mRNA translation and potentiates CAR T cells for solid tumor eradication https://t.co/rdXGFi6PwN

[Creative Bioarray @CreaBioarray]

Shingles Vaccination May Shield Against Dementia
https://t.co/8BsP7j5uro
https://t.co/pRJDryLZDI

[Creative Bioarray @CreaBioarray]

The ciPSC medium supplemented with activin and IWR1 stabilizes ciPSCs and reduces heterogeneity. It enables ciPSC differentiation into cardiomyocytes with functional traits. https://t.co/FlN9bKVBgw

[Creative Bioarray @CreaBioarray]

Kuthethur et al. demonstrated that depletion of the AAA+ ATPase FIGNL1 in BRCA2-deficient cells restored RAD51 loading and rescued HR defects, suggesting that recombination failure in BRCA2-deficient cells is primarily due to excessive removal of RAD51 by FIGNL1.